Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Investors increased their allocations to pharmaceuticals (NYSEARCA:PJP), (NYSEARCA:XPH), (PPH), banks (KRE) and industrials ...

A brief filed with the U.S. Supreme Court yesterday urged the Justices to deny a petition to the Court contending the U.S.

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

Urogen's UGN-102 presents a $5B market opportunity for bladder cancer treatment, despite risks. Read more about URGN stock ...

With the respiratory illness season starting up in earnest, Vicks has reclaimed the top Rx and over-the-counter (OTC) pharma ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with ...

Ascendis Pharma (ASND) is scheduled to announce Q3 earnings results on Thursday, November 14th, after market close. The ...